Rimonci Capital is a venture capital firm focused on visual science innovation, investing in early-stage companies in ophthalmology, optometry, and neuro-ophthalmology across the U.S., Israel, Europe, and Greater China. Founded in 2016, it supports advancements in medical and IT solutions, leveraging its expertise and ecosystem to drive clinical and commercial success in the visual science field